Fig. 4
From: Defining type 2 asthma and patients eligible for dupilumab in Italy: a biomarker-based analysis
Overview of estimated dupilumab-eligible patient population, in Italy
Fig. 4 | Clinical and Molecular Allergy
From: Defining type 2 asthma and patients eligible for dupilumab in Italy: a biomarker-based analysis
Overview of estimated dupilumab-eligible patient population, in Italy